Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in IMVT — Immunovant, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$39,397,425
+$24,051,100 QoQ
Shares Held
1,022,513
+65.5% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#25
of 226 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Derivatives in IMVT

reported options exposure · as of Jun 30, 2026
CallValue
$7,050,990
CallShares
183,000
PutValue
$6,288,096
PutShares
163,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. IMVT ranks #13 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in IMVT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,288,096 163,200
2026-06-30 $7,050,990 183,000
2026-06-30 $39,397,425 1,022,513
2026-03-31 $3,338,496 134,400
2026-03-31 $15,346,325 617,807
2026-03-31 $11,572,956 465,900
2025-12-31 $6,586,754 259,117
2025-12-31 $4,252,766 167,300
2025-12-31 $3,042,774 119,700
2025-09-30 $1,131,624 70,200
2025-09-30 $3,936,890 244,224
2025-09-30 $3,863,964 239,700
2025-06-30 $1,512,000 94,500
2025-06-30 $1,684,688 105,293
2025-06-30 $435,200 27,200
2025-03-31 $3,158,232 184,800
2025-03-31 $1,495,836 87,527
2025-03-31 $3,653,842 213,800
2024-12-31 $6,084,750 245,650
2024-12-31 $3,923,568 158,400
2024-12-31 $2,454,707 99,100
2024-09-30 $1,679,239 58,900
2024-09-30 $5,568,202 195,307
2024-09-30 $4,592,961 161,100
2024-06-30 $3,212,668 121,692
2024-06-30 $2,851,200 108,000
2024-06-30 $1,098,240 41,600
2024-03-31 $8,174,430 253,000
2024-03-31 $7,872,104 243,643
2024-03-31 $7,062,966 218,600
2023-12-31 $9,542,445 226,500
2023-12-31 $8,371,736 198,712
2023-12-31 $18,646,738 442,600
2023-09-30 $11,313,533 294,700
2023-09-30 $15,206,279 396,100
2023-09-30 $4,466,139 116,336
2023-06-30 $3,057,964 161,200
2023-06-30 $337,950 17,815
2023-06-30 $1,542,261 81,300
2023-03-31 $573,870 37,000
2023-03-31 $2,202,869 142,029
2023-03-31 $1,810,017 116,700
2022-12-31 $1,867,300 105,200
2022-12-31 $377,169 21,249
2022-09-30 $71,781 12,864
2022-09-30 $530,658 95,100
2022-06-30 $79,630 20,418
2022-06-30 $446,550 114,500
2022-06-30 $115,440 29,600
2022-03-31 $614,365 111,500